About Cartilix
Cartilix is a company based in Foster City (United States) founded in 2004 was acquired by Biomet in October 2009. Cartilix has raised $6.5 million across 2 funding rounds from investors including Biomet and De Novo Ventures. Cartilix operates in a competitive market with competitors including Theradaptive, MiMedx Group, Ossio, RevBio and Aziyo Biologics, among others.
- Headquarter Foster City, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cartilix
Cartilix has successfully raised a total of $6.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.5 million completed in June 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cartilix
Cartilix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Biomet and De Novo Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Orthopedic surgical and non-surgical products are designed and distributed.
|
Locked | Locked | Locked |
Investor details for Cartilix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cartilix
Investment portfolio details for Cartilix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cartilix
Detailed financials for Cartilix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cartilix Comparisons
Peer comparison for Cartilix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cartilix
Cartilix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, MiMedx Group, Ossio, RevBio and Aziyo Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| Locked | Locked | Locked |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| Locked | Locked | Locked |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| Locked | Locked | Locked |
Synthetic adhesives for bone and dental repair are developed.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| Locked | Locked | Locked |
Developer of stem cells to regrow damaged bones
|
Detailed competitors of Cartilix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cartilix
Complete news archive for Cartilix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cartilix
Cartilix was founded in 2004.
Cartilix is headquartered in Foster City, United States. It is registered at Foster City, California, United States.
Cartilix is a funded company, having raised a total of $6.5M across 2 funding rounds to date.
Cartilix was founded in 2004 in Foster City, United States, within the biotechnology sector focused on orthopedic solutions. Operations centered on advancing cartilage repair through ChonDux, a technology that employs a biological adhesive and hydrogel to address articular cartilage lesions in knees. The company was acquired by Biomet in 2009 for an undisclosed sum, concluding its independent activities.
Cartilix's top competitors include EpiBone, Theradaptive and MiMedx Group.
Cartilix has 2 investors. Key investors include Biomet, and De Novo Ventures.